EC5026
EC5026 has the potential to relieve pain by stabilizing natural analgesic and anti-inflammatory mediators. EC5026 (BPN-19186) is a first-in-class, small molecule that potently inhibits soluble Epoxide Hydrolase (sEH), a key regulatory enzyme involved in the metabolism of membrane fatty acids. Inhibition of sEH treats pain by stabilizing natural analgesic and anti-inflammatory mediators.
Product Specifications
CAS Number
1809885-32-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
405.39
Molecular Formula
C18H23F4N3O3
Notes
Research use only, not for human use.
Receptor
SEH
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
32-8363-50 50 µg
Recombinant Human Platelet-Derived Growth Factor AA/PDGF-AA
Sign In for Pricing
View Details 
ARP51904_P050 100 µL
SLC47A2 antibody - C-terminal region (ARP51904_P050)
Sign In for Pricing
View Details